Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression

Clinical trial NCT04738812 · COMPLETED

Trial details

NCT number: NCT04738812
Sponsor: ANRS, Emerging Infectious Diseases
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberculosis HIV-1-infection Immuno-Deficiency

Start date: 2022-04-21
Primary completion: 2025-11-12
Enrollment: 1330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.